Ghost Tree Capital, LLC Aerovate Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.68 - $29.57 $265,200 - $443,550	15,000 Added 7.14%	225,000 $6.65 Million
Q4 2023 Feb 14, 2024	BUY	$9.58 - $24.25 $84,332 - $213,472	8,803 Added 4.38%	210,000 $4.75 Million
Q2 2023 Aug 14, 2023	BUY	$15.63 - $22.01 $18,709 - $26,345	1,197 Added 0.6%	201,197 $3.45 Million
Q1 2023 May 15, 2023	BUY	$19.17 - $27.7 $1.25 Million - $1.8 Million	65,000 Added 48.15%	200,000 $4.03 Million
Q4 2022 Feb 14, 2023	SELL	$15.92 - $30.52 $238,800 - $457,800	-15,000 Reduced 10.0%	135,000 $3.96 Million
Q3 2022 Nov 14, 2022	BUY	$14.77 - $25.79 $2.22 Million - $3.87 Million	150,000 New	150,000 $2.49 Million

28.4M

116K

26.6K

Ticker AVTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,448,100
Market Cap $63.6M
Description
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.